Riskpilot← Back to searchSign inGet full accessEviprakt AB
ABActiveOrg 5565025359Kungsladugårdsgatan 75Medical specialists activities · NACE 8622Est. 19950 employees
Revenue 2024
SEK 173K
+10% vs 2023
EBITDA margin
41.4%
+267% vs 2023
Equity ratio
93.0%
Financial strength
Net profit 2024
SEK 59K
-14% vs 2023
| Revenue | SEK 173K | +10% |
| EBITDA | SEK 72K | +267% |
| Net profit | SEK 59K | -14% |
| Total assets | SEK 910K | -13% |
| Equity | SEK 847K | -15% |
| Employees | 0 | — |
Legal name
Eviprakt AB
Org number
5565025359
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 januari 1995
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva läkarpraktik, undervisning och utbildning, medicinsk konsultationsverksamhet, handel med och förvaltning av fastigheter, kapitalförvaltning samt därmed förenlig verksamhet
Address
Kungsladugårdsgatan 75
Phone
+4631675558
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 691 | 402 | 416 | 157 | 173 |
| Staff expenses | — | — | — | −6 | −4 |
| EBITDA | 567 | 258 | 277 | 20 | 72 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 567 | 258 | 277 | 20 | 72 |
| Net financials | −65 | — | 156 | 68 | 3 |
| Profit before tax | 533 | 257 | 434 | 88 | 75 |
| Tax | −122 | −54 | −84 | −20 | −16 |
| Net profit | 411 | 203 | 350 | 68 | 59 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 305 | 1 057 | 1 229 | 1 048 | 910 |
| Equity | 949 | 965 | 1 119 | 992 | 847 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 356 | 92 | 109 | 56 | 63 |
| Total debt | 356 | 92 | 109 | 56 | 63 |
EBITDA margin
41.4%
This company
15.8%
Market median
+162% vs market
20202024
Equity ratio
93.0%
This company
38.2%
Market median
+143% vs market
20202024
Return on equity
6.9%
This company
18.4%
Market median
-63% vs market
20202024
Net profit margin
33.9%
This company
8.1%
Market median
+319% vs market
20202024
Asset turnover
0.19×
This company
1.12×
Market median
-83% vs market
20202024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
BR Audit | Audit | 2020 – 2022 |
SH Auditor Substitute | Auditor Substitute | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Eviprakt AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt Rune Attsell | Audit | 0 companies |
| Sara Helena Katarina Nilsson | Auditor Substitute | 0 companies |
| Maj Inger Wallin | Board of Directors | 0 companies |
| Anders Peter Wallin | Deputy Board Member | 0 companies |